H 142

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 597553

CAS#: 85139-12-4

Description: H 142 is a decapeptide inhibitor of human renin.

Chemical Structure

H 142
CAS# 85139-12-4

Theoretical Analysis

MedKoo Cat#: 597553
Name: H 142
CAS#: 85139-12-4
Chemical Formula: C60H91N17O10
Exact Mass: 1,209.71
Molecular Weight: 1,210.490
Elemental Analysis: C, 59.53; H, 7.58; N, 19.67; O, 13.22

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Synonym: H 142; H-142; H142;

IUPAC/Chemical Name: ((S)-2-((S)-2-((S)-2-((S)-1-(L-prolyl-L-histidyl)pyrrolidine-2-carboxamido)-3-phenylpropanamido)-3-(1H-imidazol-4-yl)propanamido)-4-methylpentyl)-L-valyl-L-isoleucyl-L-histidyl-L-lysine


InChi Code: InChI=1S/C60H91N17O10/c1-7-37(6)51(58(84)74-47(26-40-29-63-33-68-40)55(81)71-44(60(86)87)17-11-12-20-61)76-57(83)50(36(4)5)66-31-42(23-35(2)3)70-53(79)46(25-39-28-62-32-67-39)72-54(80)45(24-38-15-9-8-10-16-38)73-56(82)49-19-14-22-77(49)59(85)48(27-41-30-64-34-69-41)75-52(78)43-18-13-21-65-43/h8-10,15-16,28-30,32-37,42-51,65-66H,7,11-14,17-27,31,61H2,1-6H3,(H,62,67)(H,63,68)(H,64,69)(H,70,79)(H,71,81)(H,72,80)(H,73,82)(H,74,84)(H,75,78)(H,76,83)(H,86,87)/t37-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-/m0/s1

SMILES Code: NCCCC[C@@H](C(O)=O)NC([C@H](CC1=CNC=N1)NC([C@H]([C@@H](C)CC)NC([C@H](C(C)C)NC[C@@H](NC([C@H](CC2=CNC=N2)NC([C@H](CC3=CC=CC=C3)NC([C@H]4N(C([C@H](CC5=CNC=N5)NC([C@H]6NCCC6)=O)=O)CCC4)=O)=O)=O)CC(C)C)=O)=O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

Product Data:

Preparing Stock Solutions

The following data is based on the product molecular weight 1210.490000000000000000000000000000 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Webb DJ, Cumming AM, Leckie BJ, Lever AF, Morton JJ, Robertson JI, Szelke M, Donovan B. Reduction of blood pressure in man with H-142, a potent new renin inhibitor. Lancet. 1983 Dec 24-31;2(8365-66):1486-7. PubMed PMID: 6140568. 2: Tree M, Atrash B, Donovan B, Gamble J, Hallett A, Hughes M, Jones DM, Leckie B, Lever AF, Morton JJ, et al. New inhibitors of human renin tested in vitro and in vivo in the anaesthetized baboon. J Hypertens. 1983 Dec;1(4):399-403. PubMed PMID: 6398331. 3: Hofbauer KG, Ménard J, Michel JB, Wood JM. Inhibition of renin in the primate Callithrix jacchus (common marmoset). Clin Exp Hypertens A. 1983;5(7-8):1237-47. PubMed PMID: 6196144. 4: Tree M, Szelke M, Leckie B, Atrash B, Donovan B, Hallett A, Jones DM, Lever AF, Morton JJ, Sueiras-Diaz J, et al. Renin inhibitors: their use in understanding the role of angiotensin II as a pressor hormone. J Cardiovasc Pharmacol. 1985;7 Suppl 4:S49-52. PubMed PMID: 2412013. 5: Foundling SI, Cooper J, Watson FE, Cleasby A, Pearl LH, Sibanda BL, Hemmings A, Wood SP, Blundell TL, Valler MJ, et al. High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes. Nature. 1987 May 28-Jun 3;327(6120):349-52. PubMed PMID: 3295561. 6: Gómez J, Semo N, Freire E. Structural thermodynamic study of the binding of renin inhibitors to endothiapepsin. Adv Exp Med Biol. 1998;436:325-8. PubMed PMID: 9561236. 7: Movahedi S, Norey CG, Kay J, Heale JB. Infection and pathogenesis of cash crops by Botrytis cinerea: primary role of an aspartic proteinase. Adv Exp Med Biol. 1991;306:213-6. PubMed PMID: 1812708. 8: Teleman O, Lindberg M, Engström S. Molecular dynamics simulation of the renin inhibitor H142 in water. J Comput Aided Mol Des. 1991 Jun;5(3):187-203. PubMed PMID: 1919616. 9: Webb DJ, Manhem PJ, Ball SG, Inglis G, Leckie BJ, Lever AF, Morton JJ, Robertson JI, Murray GD, Ménard J, et al. A study of the renin inhibitor H142 in man. J Hypertens. 1985 Dec;3(6):653-8. PubMed PMID: 3910726. 10: Webb DJ, Manhem PJ, Ball SG, Inglis G, Leckie BJ, Lever AF, Morton JJ, Robertson JI, Murray GD, Ménard J, et al. Clinical and biochemical effects of the renin inhibitor H142 in humans. J Cardiovasc Pharmacol. 1987;10 Suppl 7:S69-74. PubMed PMID: 2485066. 11: Webb DJ, Manhem PJ, Leckie BJ, Lever AJ, Morton JJ, Robertson JI, Semple PF, Szelke M. Severe hypotension with bradycardia during renin inhibition with H142 in sodium deplete man. J Hum Hypertens. 1989 Aug;3(4):227-32. PubMed PMID: 2677374. 12: Hofbauer KG, Fuhrer W, Heusser C, Wood JM. Comparison of different drug interference with the renin-angiotensin system. J Cardiovasc Pharmacol. 1985;7 Suppl 4:S62-8. PubMed PMID: 2412016. 13: Cooper JB, Foundling SI, Hemmings A, Watson FE, Sibanda BL, Blundell TL, Jones DM, Hallett A, Atrash B, Szelke M. Inhibitors of aspartic proteinases and their relevance to the design of antihypertensive agents. Biochem Soc Trans. 1987 Aug;15(4):751-4. PubMed PMID: 3119394. 14: Hofbauer KG, Wood JM. Inhibition of renin: recent developments. Contrib Nephrol. 1984;43:144-52. Review. PubMed PMID: 6207982.